ChemLifeIntel
Access
ChemLifeIntel/Companies/Mckesson Medical-Surgical Inc. Corporate Office

Mckesson Medical-Surgical Inc. Corporate Office

HIGH RISKHQ: — · Private · Founded —
LISTINGPrivateFOUNDED0
FOCUS THERAPY AREAS
Manufacturer
COMPANY INTELLIGENCE SNAPSHOTlive
0
Manufacturing Sites
3
Intelligence Briefs
0
Active Regulatory Actions
—
HQ Country
NO ACTIVE REGULATORY ACTIONSClean compliance footprint across 0 monitored sites · HQ
View regulatory detail

INTELLIGENCE

Showing 3 of 3 briefs on Mckesson Medical-Surgical Inc. Corporate Office
REGULATORY INTELLIGENCE·Recall

McKesson Recalls Amgen's EVENITY Due to Cold Chain Failures: A Recurring Distribution Risk

McKesson Medical-Surgical Inc. is conducting a voluntary Class II recall of Amgen's EVENITY (romosozumab-aqqg) injection due to CGMP deviations and potential temperature excursions during transit. This event, affecting distribution in OH, VA, FL, signals recurring systemic issues in McKesson's cold chain integrity, following similar recalls in 2024. Procurement and regulatory teams must reassess distribution partner compliance to mitigate supply chain risks for temperature-sensitive biologics.

90-Day Activity
Mckesson Medical-SurgicalEVENITY
RMRohan Mehta· Senior Supply Chain Intelligence Analyst
2025-07-30▲ Trending signal
REGULATORY INTELLIGENCE·Recall

McKesson Recall of Pfizer's Bicillin L-A Highlights Critical Distributor Storage Compliance Gaps

McKesson Medical-Surgical Inc. initiated a Class II recall (D-0373-2024) of 70 vials of Pfizer's Bicillin L-A (Penicillin G Benzathine) due to storage outside label specifications. This event, now terminated, underscores critical cGMP compliance risks within pharmaceutical distribution, urging procurement and supply chain leaders to enhance due diligence on distributor storage protocols to safeguard product integrity and patient safety.

90-Day Activity
Mckesson Medical-Surgical
CMCatherine Morrow· Senior Regulatory Intelligence Analyst
2024-03-20
REGULATORY INTELLIGENCE·Recall

McKesson Recall of Infuvite Adult Multiple Vitamins Highlights Critical Distribution Storage Compliance Gaps

McKesson Medical-Surgical Inc. initiated a Class II recall (D-0372-2024) for 70 vials of Infuvite Adult Multiple vitamins injection due to storage outside label specifications. This terminated recall highlights critical cGMP compliance gaps within pharmaceutical distribution networks. Procurement and regulatory teams must scrutinize distributor storage protocols to mitigate supply chain disruptions and ensure product integrity for essential medicines.

90-Day Activity
Mckesson Medical-Surgical
RMRohan Mehta· Senior Supply Chain Intelligence Analyst
2024-03-20